GPR62: A Drug Target / Disease Biomarker (G118442)

Target Name: GPR62

NCBI ID: G118442

GPR62: A Drug Target / Disease Biomarker

GPR62, also known as G protein-coupled receptor 62, is a protein that is expressed in many tissues throughout the body. It is a member of the G protein-coupled receptor family, which is a large superfamily of transmembrane proteins that play a key role in cellular signaling. GPR62 is involved in a wide range of physiological processes, including sensory perception, neurotransmitter signaling, and hormone regulation.

GPR62 is a potential drug target for several diseases, including cancer, neurodegenerative diseases, and psychiatric disorders. Its function as a drug target makes it an attractive target for researchers to study and develop new treatments.

One of the key reasons why GPR62 is a promising drug target is its diverse function. GPR62 is involved in a wide range of physiological processes, including sensory perception, neurotransmitter signaling, and hormone regulation. It is expressed in many tissues throughout the body, including the brain, spinal cord, heart, kidneys, and intestine.

GPR62 is also a member of the G protein-coupled receptor family, which is a large superfamily of transmembrane proteins that play a key role in cellular signaling. This family includes many well-known drugs, such as the beta blockers used to treat heart disease and the opioids used to treat pain.

GPR62 is involved in a wide range of physiological processes, including sensory perception, neurotransmitter signaling, and hormone regulation.

GPR62 is also involved in several diseases, including cancer, neurodegenerative diseases, and psychiatric disorders. Its function as a drug target makes it an attractive target for researchers to study and develop new treatments.

One of the key reasons why GPR62 is a promising drug target is its diverse function. GPR62 is involved in a wide range of physiological processes, including sensory perception, neurotransmitter signaling, and hormone regulation. It is expressed in many tissues throughout the body, including the brain, spinal cord, heart, kidneys, and intestine.

GPR62 is also a member of the G protein-coupled receptor family, which is a large superfamily of transmembrane proteins that play a key role in cellular signaling. This family includes many well-known drugs, such as the beta blockers used to treat heart disease and the opioids used to treat pain.

GPR62 is one of the most promising drug targets for cancer, neurodegenerative diseases, and psychiatric disorders. Its functions as a drug target make it an attractive target for researchers to study and develop new treatments.

GPR62 has been shown to play a key role in a wide range of physiological processes. For example, GPR62 is involved in the perception of pain, neurotransmitter signaling, and hormone regulation. It is also involved in the regulation of cellular signaling pathways, including the production of neurotransmitters such as dopamine and serotonin.

GPR62 is a potential drug target for several diseases, including cancer, neurodegenerative diseases, and psychiatric disorders. Its diverse function as a protein makes it an attractive target for researchers to study and develop new treatments.

One of the key reasons why GPR62 is a promising drug target is its diverse function. GPR62 is involved in a wide range of physiological processes, including sensory perception, neurotransmitter signaling, and hormone regulation. It is expressed in many tissues throughout the body, including the brain, spinal cord, heart, kidneys, and intestine.

GPR62 is also a member of the G protein-coupled receptor family, which is a large superfamily of transmembrane proteins that play

Protein Name: G Protein-coupled Receptor 62

Functions: Orphan G-protein coupled receptor. Constitutively activates the G(q/11)/inositol phosphate and the G(s)-alpha/cAMP signaling pathways (PubMed:28827538). Has spontaneous activity for beta-arrestin recruitment (PubMed:28827538). Shows a reciprocal modulation of signaling functions with the melatonin receptor MTNR1B most likely through receptor heteromerization (PubMed:28827538)

More Common Targets